Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,604,526
-
Total 13F shares
-
31,480,344
-
Share change
-
+1,195,784
-
Total reported value
-
$647,938,114
-
Put/Call ratio
-
20%
-
Price per share
-
$20.58
-
Number of holders
-
133
-
Value change
-
+$50,515,665
-
Number of buys
-
72
-
Number of sells
-
60
Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2019
As of 31 Dec 2019,
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,480,344 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, FRAZIER MANAGEMENT LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Rock Springs Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, RICE HALL JAMES & ASSOCIATES, LLC, and EMERALD ADVISERS, LLC.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.